To test this, we analysed the IC in adenocarcinoma of the lung, which has the highest frequency of KEAP1 mutations of any lineage profiled by the TCGA network to date (Fig. 3g)31. This evidence concerns the gene KEAP1 and lung adenocarcinoma.